Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Medtronic embolization devices recall to impact flow diverting stents market sales, says GlobalData

Medtronic’s latest recall of the embolization devices Pipeline Vantage 027 and 021 are likely to result in revenue losses in the flow diverting stents market. While the market is projected to grow steadily, the recall may prompt healthcare providers to consider alternative devices, creating opportunities for competitors like Stryker and Terumo in the short-term, according […]
Read more

US cable MVNOs offer lowest total cost of ownership for Apple, Samsung, Google flagship phones, finds GlobalData

Cable companies’ mobile virtual network operators (MVNOs) are leading the US wireless market by offering the lowest total cost of ownership (TCO) for popular flagship devices from Apple, Samsung, and Google. By combining competitive pricing on devices and service plans, they provide an attractive alternative to traditional postpaid carriers, focusing on home internet customers and […]
Read more

AGA new UC guidance will reshape market access and therapeutic competition, says GlobalData

The American Gastroenterological Association (AGA) has recently released a major update to its clinical guideline for the pharmacological management of moderate-to-severe ulcerative colitis (UC). The new “living” guideline strongly recommends the early use of biologics and small-molecule therapies following 5-ASA failure, a significant departure from the traditional step-up approach. It marks a turning point in […]
Read more

Pharma majors expand US manufacturing amid tariff pressures as BRICS boost biosimilar access, reveals GlobalData

Major pharmaceutical companies including Eli Lilly, Pfizer, and Merck are ramping up manufacturing investments in the US to navigate the evolving trade tariffs and capitalize on domestic tax incentives. While this strategic shift supports supply chain resilience, it may also elevate production costs and drug prices—raising concerns around affordability as emerging markets pursue regulatory reforms […]
Read more

India VC funding landscape shows promising growth in early 2025, outpacing global trends, says GlobalData

India’s venture capital (VC) ecosystem has outpaced global trends, recording a strong growth during January–February 2025 with a staggering around 40% year-on-year (YoY) jump in funding value and around 11% increase in deal volume. This surge highlights India’s resilience and underscores growing investor confidence in the country’s dynamic and innovation-driven startup landscape, reveals GlobalData, a […]
Read more

India’s diagnostic imaging market set to surpass $7 billion in 2033, with portable imaging leading accessibility push, reveals GlobalData

India’s diagnostic imaging market is poised for substantial growth, driven by rising healthcare expenditure, increasing chronic disease burden, and a growing demand for accessible diagnostic solutions. Against this backdrop, the market is expected to exceed $7 billion in 2033, growing at a compound annual growth rate (CAGR) of approximately 7%, forecasts GlobalData, a leading data […]
Read more

Ultra-portable mini C-arms poised to transform point-of-care imaging, but face adoption hurdles, says GlobalData

The latest generation of ultra-portable mini C-arms are reshaping point-of-care imaging by offering compact, standalone solutions suited for tight spaces and mobile use. Recently showcased at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting 2025, these lightweight systems enable real-time diagnostics outside traditional settings. However, their success will depend on balancing portability with image […]
Read more

UK small business market the new battleground for B2B telecoms, says GlobalData

Telcos around the world have pivoted to target smaller businesses for the opportunity to grow their enterprise revenues, says GlobalData, a leading data and analytics company. Robert Pritchard, Principal Analyst, Enterprise Technology & Services at GlobalData, says: “Deglobalization and hypercompetition in the multi-national corporation (MNC), large corporate, and public sector segments of the telecoms market […]
Read more

GlobalData forecasts China neurosurgical robotics market to grow at 10% CAGR through 2036

The neurosurgical robotics market in China is experiencing robust growth, driven by the increasing incidence of neurological disorders, an expanding elderly population, and the escalating necessity for precision-oriented, minimally invasive procedures that enhance clinical results and reduce recovery times. Owing to these factors, the neurosurgery robotic surgical systems market will expand at a compound annual […]
Read more

What’s next for corporate net zero? Join GlobalData’s webinar to find out how to adapt your ESG strategy

Decarbonization has become one of the most disruptive trends across all industries. Virtually every major company in every sector now has a strategy for reaching net-zero greenhouse gas emissions. This impacts their relationships with suppliers, clients, and customers and drives investment in new technologies, says GlobalData, a leading data and analytics company. Against this backdrop, […]
Read more

US, China dominate global robotics VC landscape with around 75% share of investments raised during 2018-2024, reveals GlobalData

The global robotics venture capital (VC) funding landscape has seen cyclical investment patterns between 2018 and 2024, with the US and China emerging as dominant forces. Together, these markets accounted for approximately 75% of global VC funding in robotics, reinforcing their leadership in driving innovation, attracting investor interest, and shaping the future of automation and […]
Read more

China VC funding value nosedives more than 35% during January-February 2025, reveals GlobalData

As the world’s second-largest economy, China has historically been a powerhouse for venture capital (VC) funding activity. However, the January-February 2025 data reveals a sharp year-on-year (YoY) decline of more than 20% in VC deals volume. Concurrently, the total deals value experienced a staggering more than 35% drop, reveals GlobalData, a leading data and analytics […]
Read more

Laplace transcatheter valve faces challenges beyond just regulatory approval, says GlobalData

Laplace Interventional, a US-based medical device company focusing on transcatheter valve technology, recently announced the successful completion of a Series C funding round to support an early feasibility study of its transcatheter tricuspid valve replacement system. While the study is a key step toward regulatory approval and market access, the company faces challenges beyond regulatory […]
Read more

Japan to rejuvenate pharma landscape with new Government fund and policy reforms, says GlobalData

Japan’s Ministry of Health, Labor, and Welfare (MHLW) announced a new 10 year government fund in January 2025 to support innovative drug development. The initiative signals a stronger push towards pro-innovation policies, aiming to strengthen drug discovery capabilities and build a more resilient pharmaceutical ecosystem in the country, says GlobalData, a leading data and analytics […]
Read more
1 … 36 37 38 39 40 … 209